skip to content

Cambridge Academy of Therapeutic Sciences


Practical Application of Toxicology in Drug Development Course

Date: September 11 - October 09 2023

Location: This course will take place online. Pre-recorded lectures will be available prior to the live sessions.


This highly acclaimed course will provide training in toxicology as applied in drug development to scientists from all parts of the world. Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with an emphasis on the practical application of these principles and the interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective.

The course is intended to benefit those from both biotechnology and pharmaceutical companies as well as CROs working with either small or large molecules, along with those from regulatory agencies and academia who are interested in toxicology and its application in the safety assessment of drugs and medical products. Early career scientists seeking a more in-depth knowledge and understanding of the role of toxicology in safety assessment will also benefit. The course is suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) looking to make a career change to work in drug safety assessment.

The course is recognised by EUROTOX as providing 37 hours of CPD and approved by the Royal Society of Biology for 96 CPD credits.


On-demand access to the presentations will be available to registrants for unlimited viewing no later than September 01 2023 until November 09th 2023.

Virtual Features

  •  Virtual interactive case studies and break out groups   
  • Live Q&A Sessions with Speakers   
  • Recorded lectures and associated course materials with unlimited on-demand viewing


The course will take place from September 11th to October 09th 2023 and will be held virtually. Pre-recorded lectures will be made available to registrants for unlimited viewing no later than August 25th 2023. Live Q&A sessions will be held with the speakers on September 11th, 18th, 25th and October 02nd and 09th . This annual course is a collaboration between the American College of Toxicology (ACT), the British Toxicology Society (BTS) and the Cambridge Alliance on Medicines Safety (CAMS).


Registration is now open for the course until September 08th 2023.

To register your place please follow the link here to a secure payment page.

Registration rates:

2023 Registration fees 

ACT/BTS Member £1,045
Student £1,045
Non-Member £1,375
Government £1,045
Group (3 or more from same company)  
ACT/BTS Member  £935
Non-Member £1,265
Group (9 or more from same company)  
ACT/BTS Member £880
Non-Member £1,155


Note: The payment gateway for staff members will show £0. However, it is not free. For a staff member registering where fees will have to be paid by UoC , please select the option UoC Staff Registration Only. You will need to register by using an approved PO if the staff is from another department or a cost centre if within the department. This is to refrain the staff from using the university credit card or expense claim for this purpose. The staff members are in the category of non-members.

All payments will be process in GBP £

Refund Policy: We will not be able to offer refunds for virtual courses. Health-related refunds will be considered on a case-by-case basis. These special cancellation requests should be submitted in writing to A £75 processing fee will be charged for cancellations.

The course organisers recognise the challenges faced by researchers in low-and-middle income countries (LMIC), including reduced access to training opportunities and have made available a limited number of bursaries to cover the cost of registration for those who may not otherwise be able to join. Applicants should be from an LMIC country and working at a LMIC based research or government organisation.

If you would like to be considered for a PATDD bursary please send the following to by 12:00 BST until August 31st 2023:

1)- A letter of application stating why you would like to attend this course and what the benefit would be to your career and your organisation.

2)- A letter of support from your employer outlining your suitability for joining this course and the benefits it would bring. (Please note, letters of support should be submitted from an organisational email address)

Course Material

Access to the PATDD course material will be provided approximately two weeks before the start of the course. Access to this material will be restricted to those who have registered in full.


Monday September 11th 2023 12.00-14.00 BST

Pharmacology - Rob Wallis, Safety Pharmacology Consultant

Safety Pharmacology - Rob Wallis, Safety Pharmacology Consultant

DMPK and ADME, Concepts and Technologies - Kunal Taskar, GSK


Monday September 18th 2023 12.00-14.00 BST

Pathology - Vasanthi Mowat, Labcorp

Clinical Pathology - Jo Harding and Peter Cotton, Astra Zeneca

Organ Systems; Part I - John Foster, Senior Pathology Consultant

Organ Systems; Part II - Matt Jacobsen, AstraZeneca


Monday September 25th 2023 12.00 -14.00 BST

Overview of Drug Discovery and Development;  Ruth Roberts, Apconix

Genetic Toxicology - George Johnson, Swansea University

Carcinogenicity - Nigel Roome, Toxicology and Toxicologic Pathology Consultant

Reproductive/Developmental Toxicology – Gary Chellman, Charles River Laboratories

Safety of Biotechnology Products - Lolke de Haan, ADC Therapeutics


Monday October 02nd 2023 12.00-14.00 BST

Regulatory Safety Studies for Cell and Gene Therapy Products - Jan Klapwijk, Cornelis Consulting

Immunotoxicology - Marc Pallardy, Université Paris-Saclay 

Risk Assessment - Ernie Harpur, Newcastle University

Regulatory Toxicology - David Jones, Regulatory consultant


Regulatory Case Studies – Full details on date & time TBC